Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 89301-89350 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05154162
PSMA PET Additive Value for Prostate Cancer Diagnosis in Men With Negative/Equivocal MRI
PHASE3
Recruiting
660 participants
Started: Mar 2, 2022 · Completed: Mar 31, 2028
1 condition
2 sponsors
6 locations
NCT05285007
Limited Ankle Dorsiflexion and Effect on Single Limb Squats in Individuals With Patellofemoral Pain
NA
Recruiting
60 participants
Started: Mar 2, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05608694
MRI Screening in Men at High Risk of Developing Prostate Cancer
NA
Recruiting
250 participants
Started: Mar 2, 2022 · Completed: Mar 1, 2039
1 condition
1 sponsor
2 locations
NCT05435248
Phase 1/2 Study of HS-10375 in Patients with Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC)
PHASE1/PHASE2
Recruiting
354 participants
Started: Mar 2, 2022 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT05250648
Clinical Trial on HIPEC with Mitomycin C in Colon Cancer Peritoneal Metastases (GECOP-MMC)
PHASE4
Recruiting
216 participants
Started: Mar 2, 2022 · Completed: Oct 31, 2029
2 conditions
2 sponsors
31 locations
NCT04838522
A Study of Prucalopride in Breastfeeding Women With Constipation
N/A
Recruiting
12 participants
Started: Mar 2, 2022 · Completed: Oct 31, 2027
1 condition
2 sponsors
1 location
NCT05153226
GvHD Prophylaxis in Unrelated Donor HCT: Randomized Trial Comparing PTCY Versus ATG
PHASE3
Active, not recruiting
640 participants
Started: Mar 2, 2022 · Completed: Dec 31, 2026
6 conditions
1 sponsor
23 locations
NCT05068908
Brain Connectivity Patterns in Chronic Temporomandibular Joint Disorders
N/A
Recruiting
95 participants
Started: Mar 2, 2022 · Completed: Aug 31, 2026
3 conditions
1 sponsor
1 location
NCT05228431
Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer
PHASE2
Recruiting
121 participants
Started: Mar 2, 2022 · Completed: May 1, 2028
1 condition
1 sponsor
1 location
NCT05093764
Quantification of Debris Captured Using TCEP During VIV TAVR With BVF
NA
Recruiting
20 participants
Started: Mar 2, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT04049591
Higher vs. Lower Dose Heparin for PCI
NA
Recruiting
16,000 participants
Started: Mar 2, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT07087080
Plasma Metabolomics as a Tool to Distinguish PET-positive Malignant From PET-positive Benign Nodules
NA
Recruiting
350 participants
Started: Mar 2, 2022 · Completed: Nov 1, 2027
2 conditions
2 sponsors
1 location
NCT05259930
Impact of Dietary Assessment and Intervention on Outcomes in Liver Cirrhosis Patients
NA
Recruiting
130 participants
Started: Mar 2, 2022 · Completed: Aug 31, 2025
2 conditions
2 sponsors
1 location
NCT05236660
Personalised Assistive Devices Approach for Diabetic Foot Ulcer Prevention
NA
Active, not recruiting
126 participants
Started: Mar 2, 2022 · Completed: Oct 31, 2025
1 condition
2 sponsors
5 locations
NCT04951817
68Ga-PSMA PET/CT for Ra223 Assessment
NA
Recruiting
52 participants
Started: Mar 2, 2022 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT04865679
Tolerability and Feasibility Pilot Clinical Study of a Large-Diameter Nerve Cap for Protecting and Preserving Terminated Nerve Ends
NA
Active, not recruiting
15 participants
Started: Mar 2, 2022 · Completed: Dec 31, 2026
3 conditions
1 sponsor
2 locations
NCT05139381
Study for Children & Adolescent With Severe Asthma With an Eosinophilic Phenotype Treated With Mepolizumab
N/A
Active, not recruiting
148 participants
Started: Mar 2, 2022 · Completed: Mar 12, 2026
1 condition
1 sponsor
1 location
NCT05142267
Stress and Opioid Misuse Risk: The Role of Endogenous Opioid and Endocannabinoid Mechanisms
NA
Recruiting
120 participants
Started: Mar 2, 2022 · Completed: Jul 31, 2026
3 conditions
2 sponsors
1 location
NCT04742751
An Open-Label Pilot Intervention Trial to Prevent Diabetes in Prediabetic Adult Survivors of Childhood Cancer
PHASE2
Active, not recruiting
96 participants
Started: Mar 2, 2022 · Completed: Nov 30, 2026
2 conditions
4 sponsors
1 location
NCT06514079
Role of Topical Steroid Injection With Refractory Benign Esophageal Stricture Endoscopic Dilatation in Children
NA
Recruiting
21 participants
Started: Mar 2, 2022 · Completed: Aug 20, 2024
3 conditions
1 sponsor
1 location
NCT05082259
ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab
PHASE1
Recruiting
48 participants
Started: Mar 2, 2022 · Completed: Mar 16, 2026
3 conditions
4 sponsors
3 locations
NCT05207358
Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis
PHASE4
Recruiting
30 participants
Started: Mar 2, 2022 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT05069038
Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy
PHASE2
Recruiting
46 participants
Started: Mar 2, 2022 · Completed: Sep 30, 2031
1 condition
1 sponsor
1 location
NCT04973306
Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC
PHASE2/PHASE3
Recruiting
176 participants
Started: Mar 2, 2022 · Completed: Jul 31, 2027
2 conditions
16 sponsors
1 location
NCT05050864
Stenting Versus Neurosurgical Treatment of Idiopathic Intracranial Hypertension.
NA
Recruiting
276 participants
Started: Mar 2, 2022 · Completed: Mar 15, 2027
3 conditions
1 sponsor
1 location
NCT05268562
Ketamine and Kidney Injury in Cardiac Surgery
PHASE4
Active, not recruiting
200 participants
Started: Mar 2, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05217940
Screening Women With Prior HPV for Anal Neoplasia
NA
Recruiting
300 participants
Started: Mar 2, 2022 · Completed: Jan 31, 2027
3 conditions
3 sponsors
3 locations
NCT05388123
Low Dose Vemurafenib and Rituximab in Hairy Cell Leukemia
PHASE2
Active, not recruiting
20 participants
Started: Mar 2, 2022 · Completed: Dec 1, 2026
1 condition
1 sponsor
1 location
NCT05179733
The Efficacy and Safety of ZR2 Versus R-miniCHOP in the Treatment of Unfit or Frail de Novo Diffuse Large B-cell Lymphoma Patients Aged Older Than or Equal to 70 Years
PHASE3
Recruiting
280 participants
Started: Mar 2, 2022 · Completed: Dec 25, 2025
1 condition
29 sponsors
1 location
NCT05333679
Urine Tenofovir Point-of-care Test to Identify Patients in Need of ART Adherence Support (UTRA Study)
NA
Active, not recruiting
200 participants
Started: Mar 2, 2022 · Completed: Jun 30, 2025
1 condition
4 sponsors
1 location
NCT04430517
Effects of Nicotinamide Riboside on Bioenergetics and Oxidative Stress in Mild Cognitive Impairment/Alzheimer's Dementia
EARLY_PHASE1
Recruiting
50 participants
Started: Mar 2, 2022 · Completed: Apr 30, 2025
2 conditions
2 sponsors
1 location
NCT05092412
Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC
PHASE2
Active, not recruiting
30 participants
Started: Mar 2, 2022 · Completed: Jun 30, 2025
3 conditions
2 sponsors
3 locations
NCT05175248
Nutritional Intervention for Endometriosis
NA
Recruiting
120 participants
Started: Mar 2, 2022 · Completed: Nov 30, 2025
1 condition
1 sponsor
1 location
NCT04962477
Understanding Host-pathogen Interaction in the Respiratory Mucosa During Pregnancy
N/A
Active, not recruiting
30 participants
Started: Mar 2, 2022 · Completed: Sep 30, 2025
2 conditions
1 sponsor
1 location
NCT05057715
huCART-meso + VCN-01 in Pancreatic and Ovarian Cancer
PHASE1
Active, not recruiting
13 participants
Started: Mar 2, 2022 · Completed: Sep 30, 2038
2 conditions
2 sponsors
1 location
NCT04667078
REperfusion With P2Y12 Inhibitors in Addition to mEchanical thRombectomy for perFUsion Imaging Selected Acute Stroke patiEnts
PHASE3
Recruiting
368 participants
Started: Mar 2, 2022 · Completed: Jan 2, 2027
1 condition
2 sponsors
9 locations
NCT05090371
A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation
PHASE4
Recruiting
150 participants
Started: Mar 2, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
43 locations
NCT04905017
Trisol System EFS Study
NA
Recruiting
15 participants
Started: Mar 2, 2022 · Completed: Jul 31, 2027
1 condition
1 sponsor
4 locations
NCT05597410
Shanghai At Risk for Alzheimer's Disease: a Cohort Study
N/A
Recruiting
3,418 participants
Started: Mar 1, 2022 · Completed: Mar 31, 2030
5 conditions
1 sponsor
1 location
NCT05823766
Transforming Research and Clinical Knowledge in Traumatic Brain Injury Epileptogenesis Project (TRACK-TBI EPI)
N/A
Active, not recruiting
300 participants
Started: Mar 1, 2022 · Completed: Feb 28, 2027
2 conditions
2 sponsors
9 locations
NCT06626893
"Integrative Omics Approaches for Leukemia Target Identification and Matched Therapeutic Intervention"
NA
Recruiting
100 participants
Started: Mar 1, 2022 · Completed: Mar 1, 2025
2 conditions
1 sponsor
8 locations
NCT05272696
Pembrolizumab and Induction Chemotherapy in Locally Advanced HNSCC
PHASE2
Recruiting
86 participants
Started: Mar 1, 2022 · Completed: Jan 1, 2026
1 condition
1 sponsor
1 location
NCT05566054
Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia
PHASE2
Recruiting
92 participants
Started: Mar 1, 2022 · Completed: Sep 30, 2025
2 conditions
8 sponsors
1 location
NCT05132439
MetfOrmin BenefIts Lower Extremities With Intermittent Claudication
PHASE3
Recruiting
200 participants
Started: Mar 1, 2022 · Completed: Feb 28, 2031
1 condition
4 sponsors
1 location
NCT05500599
Effects on Recovery of Children of Intravenous Formulation of Fentanyl Citrate and Midazolam Orally for Premedication
NA
Active, not recruiting
60 participants
Started: Mar 1, 2022 · Completed: Aug 28, 2025
1 condition
1 sponsor
1 location
NCT05199259
Multi-analyte Blood Test Clinical Trial
N/A
Recruiting
1,200 participants
Started: Mar 1, 2022 · Completed: Mar 31, 2025
4 conditions
1 sponsor
7 locations
NCT05148871
Australian Phase 2b Study to Assess Effect of Dose Interval on Spikogen Covid-19 Vaccine
PHASE2/PHASE3
Active, not recruiting
200 participants
Started: Mar 1, 2022 · Completed: Oct 6, 2024
1 condition
3 sponsors
1 location
NCT05301478
Patient Specific 3D Printed Diabetic Insoles to Reduce Plantar Pressure
NA
Active, not recruiting
25 participants
Started: Mar 1, 2022 · Completed: Mar 30, 2026
1 condition
1 sponsor
1 location
NCT06405464
Cabotegravir Plus Rilpivirine Long-acting Regimen in the Swiss HIV Cohort Study:Uptake, Outcome, and Risk Factors for Treatment Failures
N/A
Recruiting
600 participants
Started: Mar 1, 2022 · Completed: Jun 30, 2026
1 condition
2 sponsors
1 location
NCT06111989
Fitness to Drive Among Stroke Patients
N/A
Recruiting
100 participants
Started: Mar 1, 2022 · Completed: Dec 31, 2024
2 conditions
2 sponsors
1 location
Previous
1
More pages
1784
1785
1786
1787
1788
1789
1790
More pages
2369
Next